Freya Semaglutide: the Brand, the Evidence, and What UK Patients Need to Know

What the clinical evidence actually shows about semaglutide for weight loss

The strongest data for semaglutide in weight management comes from the STEP trial programme. In STEP 1, published in the New England Journal of Medicine, adults with obesity or overweight plus a weight-related condition took 2.4mg semaglutide weekly for 68 weeks alongside reduced-calorie eating and physical activity. Average body weight fell by around 15%, compared with under 3% in the placebo group. These were not outliers — the trial ran across multiple countries with a large, representative cohort.

NICE assessed this evidence in its appraisal of Wegovy (TA875) and recommended semaglutide for use within specialist weight management services, for a maximum of two years, in adults with a BMI of 35 or above and at least one weight-related comorbidity. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. The treatment is stopped if less than 5% weight loss is achieved after six months on the maintenance dose.

More recently, the MHRA approved a 7.2mg semaglutide maintenance dose. The dedicated single-dose 7.2mg Wegovy pen was cleared on 14 April 2026 for adults with a BMI of 30 or above. Trials at this higher dose reported average weight loss of around 20.7% over 72 weeks, narrowing the gap with the results seen for tirzepatide. If you want to read more about how the two medicines compare, the semaglutide overview at nume covers the evidence side by side.

Why the Freya name appears, and what it means for safety in the UK

The Freya label has been used in connection with compounded or unlicensed semaglutide preparations, predominantly sold online and sometimes through social media channels. The MHRA has not granted a UK marketing authorisation to any Freya semaglutide product for weight management. That matters because a UK marketing authorisation is the regulatory proof that a medicine's quality, safety and efficacy have been independently verified for the British population.

Purchasing semaglutide from a source that bypasses the licensed supply chain is not simply a bureaucratic concern. The MHRA has warned publicly that fake or unregulated weight-loss pens have been found to contain incorrect or harmful substances. Around 20 million doses of illegally traded weight-loss medicines, with an estimated street value of roughly £45 million, were seized in 2025 alone. You can report a suspect seller directly through the MHRA's Yellow Card scheme.

The safe route is a prescription issued by a registered prescriber, dispensed by a pharmacy you can verify on the GPhC register. Any legitimate online pharmacy will have a registration number you can look up in seconds. Worth checking before you hand over payment details.

Side effects and practical realities of semaglutide treatment

The side-effect profile of semaglutide is well characterised after years of clinical use and large-scale trials. Gastrointestinal symptoms dominate: nausea is the most commonly reported, followed by constipation, diarrhoea, vomiting and indigestion. For most people these are most noticeable in the first days after a dose increase and then settle. Starting at the lowest dose and titrating slowly is precisely why the escalation schedule exists, your system adjusts over months, not days.

The MHRA also highlighted acute pancreatitis as a known but infrequent side effect of GLP-1 medicines. Severe stomach pain that radiates towards the back, with or without vomiting, warrants urgent medical attention. Other signals to take seriously include signs of an allergic reaction, significant dehydration from prolonged vomiting, and changes in vision if you have a history of diabetic eye disease. The NHS patient information page for semaglutide sets out the full list in plain English and is worth reading before you start.

Storage is straightforward once you are in a rhythm: the pen lives in the fridge between 2°C and 8°C. Many people keep it in the fridge door, just remember it cannot freeze. Once removed, there is a limited period it can stay at room temperature; if you are working through the semaglutide 1 dose stage, your Patient Information Leaflet gives the exact window, which varies by pen format, so check that rather than relying on a general figure. You can read more about how semaglutide affects appetite signals if you are wondering what day-to-day life on treatment actually feels like.

Getting semaglutide legally in the UK, and how private prescribing works

Wegovy is available in the UK through two routes: NHS specialist weight management services (subject to the NICE TA875 criteria and, in practice, often significant waiting times) and private prescription from a regulated provider. For people who do not meet the current NHS eligibility thresholds or prefer not to wait, a private route through a GPhC-registered pharmacy is the legal and clinically supervised alternative.

If you are considering private treatment, the cost context matters. Semaglutide's list price shifted considerably after the wider market changes in 2025, and private prices across providers typically range from around £149 to £375 per month depending on dose and what is included, with the semaglutide 2 dose tier sitting at the higher end of that range. The Wegovy cost page breaks this down so you can compare on a like-for-like basis.

A legitimate private consultation should always include a clinical assessment, your medical history, any medicines you take, your BMI and weight-related conditions. At nume, that review is done by a GPhC-registered Independent Prescriber, not by automated software. There are no subscriptions and no hidden fees; every repeat order is clinically re-reviewed before anything is dispensed. Our about us page explains how the service is structured, and you can read about our clinical team if you want to know who reviews consultations. If you have questions before starting, the FAQs cover the most common ones, or you can reach us through the contact page.

When you are ready to take the next step, a free consultation is the right place to start, not a product page.

Start your free consultation with our prescribers.